Log In
BCIQ
Print this Print this
 

Janus kinase-2 (JAK-2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Janus kinase-2 (JAK-2)

BCIQ
Print ChartPrint this
Marketed, 1 Registration, 1 Registration, 1 Phase III, 1 Phase III, 1 Phase II, 1 Phase II, 2 Phase II, 3 Phase II, 2 Phase I/II, 3 Phase I/II, 1 Phase I, 1 Phase I, 1 Phase I, 1 Preclinical, 1 Preclinical, 2 Preclinical, 3 Preclinical, 2
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIRegistrationMarketed
Autoimmune

2

1

-

2

-

1

-

Cancer

3

1

1

3

1

-

-

Hematology

2

1

3

2

1

1

1

Inflammation

1

-

-

-

-

-

-

Renal

-

-

-

1

-

-

-




 Products Targeting Janus kinase-2 (JAK-2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

12

$35,447.8M

$13,603.3M

$3,269.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today